Recent matter
12 July 2024
Rutgers & Posch advises Magnus Black and certain shareholders in relation to the sale of Magnus Black to Hardis Group
Rutgers & Posch advises Magnus Black and certain shareholders in relation to the sale of Magnus Black to Hardis Group. Consultancy firm Magnus is a major player in the field of digital transformation. With its broad IT expertise, Magnus is a respected partner with clients in diverse markets. The team of Rutgers & Posch consisted of Justus Fortuyn and Rosanne Schut.
Read more >19 June 2024
Rutgers & Posch has advised the shareholder of Granuband B.V. in relation to the sale of Granuband B.V. to Circtec Ltd.
Circtec Ltd, one of the global leaders in end-of-life tyre chemical recycling has acquired Granuband B.V., a leading Netherlands end-of-life tyre collection and recycling company. With a substantial recycling plant in the industrial port of Amsterdam, capable of processing 50,000 tonnes per year of end-of-life tyres into granulate, moulded products and tyre chips, Granuband is one of the main end-of-life tyre recycling companies in the Benelux region. The…
Read more >3 June 2024
Rutgers & Posch advises hospital SJG Weert on its collaboration with academic hospital Maastricht UMC+
Rutgers & Posch advises Hospital SJG Weert on its collaboration with academic hospital Maastricht UMC+ (MUMC+). As part of the collaboration SJG Weert will be converted into a limited liability company whereby MUMC+ acquires all shares. SJG Weert remains an independent hospital with its own management board and an independent supervisory board. The purpose of the collaboration is to ensure the accessibility of care in the province of…
Read more >8 April 2024
Rutgers & Posch advises founders on sale of Luscii Healthtech, a fast-growing scale-up in the field of digital health and remote consultation service platforms, to Omron Healthcare
Luscii Healthtech was founded in 2018. Omron Healthcare, a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, took part in the initial seed funding of Luscii Healthtech. Luscii Healthtech is the market leader in the Netherlands, where it collaborates with approximately 70% of the hospitals. In recent years it has extended the presence of its platform to other markets,…
Read more >26 March 2024
Rutgers & Posch advises the shareholders in Dutch company Bloomia B.V. in the sale of their respective participations to Lendway, Inc.
Rutgers & Posch advises the shareholders in Dutch company Bloomia B.V. in the sale of their respective participations to Lendway, Inc., a Nasdaq listed ag and finance company. The team of Rutgers & Posch consisted of Lennaert Posch, Vasco Hoving and Joost Kuipers. The press releases from Lendway and BP nieuws (in Dutch) can be read via the buttons below.
Read more >26 March 2024
Rutgers & Posch advises the Van Drie Group in relation to the sale of its Schils Food activities to the F&F Group
Rutgers & Posch advises the Van Drie Group in relation to the sale of its Schils Food activities to the F&F Group. The F&F Group is active in the diary commodites market. The team of Rutgers & Posch consisted of Bas Mees, Veerle Cordemeijer, Laura Dingemans and Rosanne Schut. The press release can be read via the button below.
Read more >